Cargando…

COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer

Dysregulation of collagen type XII α1 chain (COL12A1) has been found in several cancer types and could be involved in tumor progression. However, its clinical significance in gastric cancer (GC) remains under exploration. Online databases (Gene Expression Omnibus and UALCAN), reverse transcription-q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Xiaoxia, Wu, Mengjie, Xu, Xin, Zhang, Liwei, Huang, Yingying, Xu, Zhenzhen, He, Kuifeng, Wang, Haiyong, Wang, Haohao, Teng, Lisong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2019
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755194/ https://www.ncbi.nlm.nih.gov/pubmed/31432110 http://dx.doi.org/10.3892/mmr.2019.10548

Ejemplares similares

HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

BP-1-102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways
por: Jiang, Xiaoxia, et al.
Publicado: (2019)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer
por: Ding, Yongfeng, et al.
Publicado: (2020)

Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways
por: Wang, Haiyong, et al.
Publicado: (2017)

Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer
por: Lu, Jun, et al.
Publicado: (2015)

Establishment of a novel human cell line retaining the characteristics of the original pancreatic adenocarcinoma, and evaluation of MEK as a therapeutic target
por: Du, Xiaoxiao, et al.
Publicado: (2020)

Prognostic Value of the Combination of CEA and Fibrinogen/Albumin Ratio in Resectable Gastric Cancer
por: Zhang, Junbin, et al.
Publicado: (2020)

Overexpressed MAGP1 Is Associated With a Poor Prognosis and Promotes Cell Migration and Invasion in Gastric Cancer
por: Wu, Mengjie, et al.
Publicado: (2020)

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend
por: Zhang, Jing, et al.
Publicado: (2020)

Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets
por: Lu, Jun, et al.
Publicado: (2021)

Identification of TYROBP and C1QB as Two Novel Key Genes With Prognostic Value in Gastric Cancer by Network Analysis
por: Jiang, Junjie, et al.
Publicado: (2020)

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
por: He, Kuifeng, et al.
Publicado: (2012)

LncRNA UCA1 in anti-cancer drug resistance
por: Wang, Haohao, et al.
Publicado: (2017)

GPRC5A: An Emerging Biomarker in Human Cancer
por: Jiang, Xiaoxia, et al.
Publicado: (2018)

Combining the Fibrinogen/Albumin Ratio and Systemic Inflammation Response Index Predicts Survival in Resectable Gastric Cancer
por: Zhang, Junbin, et al.
Publicado: (2020)

COL4A family: potential prognostic biomarkers and therapeutic targets for gastric cancer
por: Zeng, Xi, et al.
Publicado: (2020)

Patient-derived xenograft models for gastrointestinal tumors: A single-center retrospective study
por: Yu, Xiongfei, et al.
Publicado: (2022)

Assessment of a Novel VEGF Targeted Agent Using Patient-Derived Tumor Tissue Xenograft Models of Colon Carcinoma with Lymphatic and Hepatic Metastases
por: Jin, Ketao, et al.
Publicado: (2011)

Gut microbiota shifts in patients with gastric cancer in perioperative period
por: Liang, Weiren, et al.
Publicado: (2019)

Advances in the targeted therapy of liposarcoma
por: Guan, Zhonghai, et al.
Publicado: (2015)

ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer
por: Chen, Chuanzhi, et al.
Publicado: (2022)

Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer
por: Chen, Xiangliu, et al.
Publicado: (2021)

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and capecitabine in patients with locally advanced, resectable gastric or gastroesophageal junction adenocarcinoma: early results of a phase 2 study
por: Jiang, Haiping, et al.
Publicado: (2022)

FH535 Inhibits Proliferation and Motility of Colon Cancer Cells by Targeting Wnt/β-catenin Signaling Pathway
por: Chen, Yanyan, et al.
Publicado: (2017)

MiR-301a-5p/SCIN promotes gastric cancer progression via regulating STAT3 and NF-κB signaling
por: Huang, Yingying, et al.
Publicado: (2021)

Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer
por: Liu, Jin, et al.
Publicado: (2022)

Association of telomerase reverse transcriptase promoter mutations with clinicopathological features and prognosis of thyroid cancer: a meta-analysis
por: Su, Xingyun, et al.
Publicado: (2016)

PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
por: Zhang, Yingzi, et al.
Publicado: (2022)

Giant appendiceal neurofibroma in von Recklinghausen’s disease: A case report and literature review
por: GUO, LIWEN, et al.
Publicado: (2014)

Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer
por: Li, Jun, et al.
Publicado: (2016)

Predicting Peritoneal Dissemination of Gastric Cancer in the Era of Precision Medicine: Molecular Characterization and Biomarkers
por: Chen, Yanyan, et al.
Publicado: (2020)

Novel prognostic biomarkers of gastric cancer based on gene expression microarray: COL12A1, GSTA3, FGA and FGG
por: Duan, Shijie, et al.
Publicado: (2018)

Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
por: Hu, Yan, et al.
Publicado: (2021)

The Essential Factors of Establishing Patient-derived Tumor Model
por: Chen, Chuanzhi, et al.
Publicado: (2021)

PN3b as an independent risk factor for poor prognosis and peritoneal recurrence in Borrmann type IV gastric cancer: A retrospective cohort study
por: Chen, Yiran, et al.
Publicado: (2022)

Lower Beclin 1 downregulates HER2 expression to enhance tamoxifen sensitivity and predicts a favorable outcome for ER positive breast cancer
por: Gu, Yu, et al.
Publicado: (2016)

EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways
por: Chen, Xiangliu, et al.
Publicado: (2022)

Microbiota and metabolites alterations in proximal and distal gastric cancer patients
por: Yang, Yan, et al.
Publicado: (2022)

Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric Cancer
por: Zhou, Jie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ldn6uoi9gk9abvmescg2bifjii